CIK: 0001608126 · Show all filings
Period: Q1 2023 (← Previous) (Next →)
Filing Date: May 12, 2023
Total Value ($000): $261,803 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| TVTX | TRAVERE THERAPEUTICS INC | 875,221 | $19,684 | 7.5% | $25.45 | -16.5% | COM | 89422G107 |
| APLS | APELLIS PHARMACEUTICALS INC | 283,690 | $18,712 | 7.1% | $47.12 | +22.4% | COM | 03753U106 |
| — | IVERIC BIO INC | 723,600 | $17,605 | 6.7% | $9.95 | — | COM | 46583P102 |
| ACAD | ACADIA PHARMACEUTICALS INC | 916,353 | $17,246 | 6.6% | $17.65 | +7.9% | COM | 004225108 |
| GLPG | GALAPAGOS NV | 444,659 | $17,182 | 6.6% | $48.81 | — | SPON ADR | 36315X101 |
| SRPT | SAREPTA THERAPEUTICS INC | 122,757 | $16,920 | 6.5% | $115.88 | +11.9% | COM | 803607100 |
| ASND | ASCENDIS PHARMA A/S | 156,072 | $16,734 | 6.4% | $88.65 | — | SPONSORED ADR | 04351P101 |
| — | SAGE THERAPEUTICS INC | 388,865 | $16,317 | 6.2% | $32.48 | — | COM | 78667J108 |
| FOLD | AMICUS THERAPEUTICS INC | 1,460,175 | $16,193 | 6.2% | $8.32 | +48.1% | COM | 03152W109 |
| PRTA | PROTHENA CORP PLC | 331,600 | $16,073 | 6.1% | $31.42 | +68.1% | SHS | G72800108 |
| — | SPRINGWORKS THERAPEUTICS INC | 614,231 | $15,810 | 6.0% | $13.68 | — | COM | 85205L107 |
| CYTK | CYTOKINETICS INC | 413,793 | $14,561 | 5.6% | $40.42 | +0.9% | COM NEW | 23282W605 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 868,427 | $13,947 | 5.3% | $17.67 | +4.7% | COM | 22663K107 |
| RLAY | RELAY THERAPEUTICS INC | 846,270 | $13,938 | 5.3% | $18.95 | -5.4% | COM | 75943R102 |
| ARVN | ARVINAS INC | 492,300 | $13,450 | 5.1% | $45.99 | -31.3% | COM | 04335A105 |
| — | CEREVEL THERAPEUTICS HLDNG I | 539,445 | $13,157 | 5.0% | $28.10 | — | COM | 15678U128 |
| SLDB | SOLID BIOSCIENCES INC | 488,857 | $2,317 | 0.9% | $6.25 | -3.9% | COM NEW | 83422E204 |
| — | ARES ACQUISITION CORP | 504,706 | $444 | 0.2% | $0.85 | — | *W EXP 02/02/202 | G33032122 |
| — | HOME PLATE ACQUISITION CORP | 690,000 | $219 | 0.1% | $0.60 | — | *W EXP 09/30/202 | 43734R111 |
| — | BRIDGETOWN HOLDINGS LTD | 895,000 | $134 | 0.1% | $1.24 | — | *W EXP 09/30/202 | G1355U121 |
| — | ROSS ACQUISITION CORP II | 439,666 | $115 | 0.0% | $0.89 | — | *W EXP 02/01/202 | G7641C114 |
| — | CONYERS PARK III ACQUISITION CORP | 571,666 | $114 | 0.0% | $1.04 | — | *W EXP 08/12/202 | 21289P110 |
| — | CHURCHILL CAPITAL CORP V | 612,000 | $114 | 0.0% | $1.30 | — | *W EXP 10/29/202 | 17144T115 |
| — | MARBLEGATE ACQUISITION CORP | 735,000 | $110 | 0.0% | $0.50 | — | *W EXP 08/31/202 | 56608A113 |
| LSBWF | YS BIOPHARMA CO LTD | 489,999 | $76 | 0.0% | $0.16 | — | *W EXP 03/15/202 | G9845F117 |
| — | CHURCHILL CAPITAL CORP VII | 548,000 | $67 | 0.0% | $0.92 | — | *W EXP 02/29/202 | 17144M110 |
| — | AFTERNEXT HEALTHTECH ACQUISITION CORP | 366,666 | $61 | 0.0% | $0.70 | — | *W EXP 99/99/999 | G01109126 |
| — | ZIMMER ENERGY TRANSITION ACQUISITION CORP | 358,270 | $60 | 0.0% | $1.34 | — | *W EXP 06/16/202 | 989570114 |
| — | JAWS HURRICANE ACQUISITION CORP | 387,249 | $60 | 0.0% | $1.15 | — | *W EXP 03/26/202 | 47201B111 |
| IVCPW | SWIFTMERGE ACQUISITION CORP | 490,000 | $60 | 0.0% | $0.21 | — | *W EXP 12/13/202 | G63836111 |
| CDAWF | COMPASS DIGITAL ACQUISITION CORP | 459,906 | $60 | 0.0% | $0.76 | — | *W EXP 09/29/202 | G2476C123 |
| — | CHURCHILL CAPITAL CORP VI | 540,000 | $59 | 0.0% | $1.20 | — | *W EXP 02/17/202 | 17143W119 |
| — | CORSAIR PARTNERING CORP | 334,666 | $54 | 0.0% | $0.76 | — | *W EXP 07/06/202 | G2540H116 |
| — | SENIOR CONNECT ACQUISITION COR | 1,014,000 | $51 | 0.0% | $0.71 | — | *W EXP 12/31/202 | 81723H116 |
| CNDAW | CONCORD ACQUISITION CORP II | 408,333 | $29 | 0.0% | $0.95 | — | *W EXP 99/99/999 | 20607U116 |
| CLDWW | FIRST LIGHT ACQUISITION GROUP INC | 655,200 | $27 | 0.0% | $0.50 | — | *W EXP 03/14/202 | 320703119 |
| — | BILANDER ACQUISITION CORP | 183,749 | $24 | 0.0% | $1.10 | — | *W EXP 05/19/202 | 09001T114 |
| — | SKYDECK ACQUISITION CORP | 361,756 | $18 | 0.0% | $0.75 | — | *W EXP 05/13/202 | G82220115 |